Abstract：
California\'s Controlled Substance Utilization Review and Evaluation System (CURES) was mandated in 2018 to monitor and limit opiate prescriptions. This study evaluated the effects of this legislation on postoperative opioid prescriptions of patients undergoing soft tissue hand surgery. Patients receiving carpal tunnel release, trigger finger release, and ganglion excisions 18 months prior to and 18 months after CURES were selected. The primary outcome was milligram morphine equivalent (MME) prescribed at the surgical encounter and at first postoperative visit. There were 758 patients in the pre-CURES cohort and 701 patients in the post-CURES cohort. In the pre-CURES cohort, there was 116.9 ± 123.8 MME prescribed post op and 10.2 ± 70.8 at first follow-up, whereas post-CURES had 58.8 ± 68.4 MME and 1.1 ± 14.1 for post-op and first follow-up respectively. Findings of this study indicate state regulations may play a role in reducing narcotic consumption following soft tissue hand surgery. (Journal of Surgical Orthopaedic Advances 33(2):122-124, 2024).
摘要：
加利福尼亚州的受控物质利用审查和评估系统（CURES）于2018年被授权监控和限制阿片类药物处方。这项研究评估了该立法对软组织手手术患者术后阿片类药物处方的影响。接受腕管松解术的患者，触发手指释放，选择CURES前18个月和后18个月的神经节切除术。主要结果是在手术相遇和术后第一次就诊时规定的毫克吗啡当量（MME）。CURES前队列中有758名患者，CURES后队列中有701名患者。在pre-CURES队列中，在第一次随访时，有116.9±123.8MME规定的手术后和10.2±70.8，而术后和首次随访的CURES分别为58.8±68.4MME和1.1±14.1。这项研究的结果表明，国家法规可能在减少软组织手手术后的麻醉剂消耗中起作用。（外科骨科杂志进展33（2）：122-124，2024）。
